Psychiatry News

  • Illicit Fentanyl the 'Third Wave' of US Opioid Crisis A rise in trafficking and use of illicit fentanyl may constitute a 'third wave' of the opioid epidemic in the United States, according to members of Congress and federal officials at a House hearing.
  • Diuretic Continues to Show Promise in Autism The diuretic bumetanide improved the core symptoms of autism spectrum disorder in a phase 2b study and will be tested in an upcoming phase 3 study in Europe.
  • Anxiety Therapy Better for Depression Than CBT? Metacognitive therapy, a psychotherapeutic approach targeting rumination and negative thought processes, has a large effect size when used to treat depression and may offer an alternative to CBT.
  • Long-term Use of ADHD Meds: No Benefit, Impact on Growth Continuing stimulant medications for attention-deficit/hyperactivity disorder (ADHD) into adulthood is associated with no symptomatic gains but a suppression of adult height, new research shows.


Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • Shake, Rattle, and Roll: Strategy Improves BP ControlThe Kaiser Permanente intervention asks participants to 'shake' the salt habit; 'rattle' the intensity of blood pressure management, and use interventions easily "rolled" out in the community.
  • Duchenne Muscular Dystrophy Drug Sold Amid ControversyFacing criticism over its $89,000-per-year price tag for a drug now available for $1000 per year, and use of 20-year-old data for FDA approval, Marathon has announced sale of deflazacort to PTC Therapeutics.


Business of Medicine

  • The State Shouldn't Tell Doctors What to Say, Says Ethicist   Dr Art Caplan, bioethicist, discusses physicians' right to talk to their patients about certain topics, including gun safety and the abortion reversal pill, in view of various state legislation.
  • Saying You're Sorry Might Not Cut It Fess up or clam up? A study weighs in; internist leads liability reform effort; physician carries taint of mega award.

Advisory Board


Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape